Lateral lumbar interbody fusion market in the US
The lateral lumbar interbody fusion market in the US is expected to register a steady CAGR of more than 7% by 2020. The lateral lumbar interbody fusion market in the US is growing at a significant rate owing to the recent increase in the incidence of degenerative diseases, such as disc degeneration and spondylolisthesis, among the aged population. Also, an increase in the preference for minimally invasive surgeries will impel market growth as it will lead to the advent of technologically advanced spinal implants.
Lateral lumbar interbody fusion market driver
Technavio’s market research analyst has estimated eminent factors, such as the augmented adoption of image-guided procedures, to spur market growth during the predicted period. This technology allows surgeons to locate precisely the entry point and the trajectory for the position of the spinal implant. Since this technology reduces the risk of injury to the nerves and nerve roots, its rising adoption by healthcare facilities will lead to market growth.
Lateral lumbar interbody fusion market key players
The lateral lumbar interbody fusion market in the US is highly competitive due to the presence of numerous large and well-established vendors. This market is subject to rapid change and is significantly affected by new product launches and other market activities of key industry participants. The companies such as Medtronic, DePuy Synthes, and Stryker are the leading players in the market but are continuously losing their market shares to smaller players due to their ability to develop unique and new products.
The top four vendors in the market
- Depuy Synthes
- Medtronic
- NuVasive
- Stryker
Growth drivers, challenges, and upcoming trends - Lateral lumbar interbody fusion
Technavio market research analysts have estimated factors, such as the rise in popularity of physician-owned ambulatory surgical centers (ASCs), to incite market growth during the predicted period. Due to the growing preference for minimally invasive surgeries, many surgeons are already performing lateral lumbar interbody fusion procedures regularly in ASCs. This gives the surgeons the opportunity to invest in setting their ASCs to perform various minimally invasive surgeries in an outpatient setting.
This report provides a number of factors contributing to the adoption, limitations, and opportunities of the lateral lumbar interbody fusion market in the US. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.
Key questions answered in the report include
- What will the market size and the growth rate be in 2020?
- What are the key factors driving the lateral lumbar interbody fusion market in the US?
- What are the key market trends impacting the growth of the lateral lumbar interbody fusion market in the US?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the vendors in the craft beer market in the US?
- What are the key outcomes of the five forces analysis of the lateral lumbar interbody fusion market in the US?
Related reports
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
PART 05: LLIF surgery: An overview
PART 06: Importance of minimally invasive technique
- Advantages and disadvantages of minimally invasive LLIF surgery
- Recent advances in minimally invasive LLIF surgery
PART 07: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 08: US healthcare reform
PART 09: Cost and benefit analysis of LLIF surgery
PART 10: Market drivers
- Increase in incidence of degenerative diseases
- Increased adoption of minimally invasive surgeries
- Rise in adoption of image guided procedure
- Growing elderly population
PART 11: Impact of drivers
PART 12: Market challenges
- Complications associated with LLIF surgery
- Lack of reimbursement for LLIF procedure
- Pricing pressure
PART 13: Impact of drivers and challenges
PART 14: Market trends
- Regulatory changes in device classification
- Introduction of new products
- Rise in popularity of physician-owned ASCs
- Increase in clinical evidence
PART 15: Vendor landscape
- Competitive scenario
- Key news
- Mergers and acquisitions
- DePuy Synthes
- Medtronic
- NuVasive
- Stryker
- Other prominent vendors
PART 16: Appendix
PART 17: Explore Technavio